Evidence map›Paper›PMID 41245813›Full record

ArticleBBA advances2025

Therapeutic potential of 7-oxo-DHEA as an adjunctive host-directed therapy for pulmonary tuberculosis.

María Belén Vecchione, Jorge Barrios-Payán, Dulce Mata-Espinosa, Ricardo Márquez Velasco, Brenda Marquina-Castillo, Denise Anabella Giannone, Milagros Victoria Acevedo, Maria Florencia Quiroga, Rogelio Hernández-Pando

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BBA advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

María Belén VecchioneUniversidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales, Departamento de Fisiología, Biología Molecular y Celular. Buenos Aires, Argentina.
Jorge Barrios-PayánInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Sección de Patología Experimental, Departamento de Patología, Ciudad de México, Mexico.
Dulce Mata-EspinosaInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Sección de Patología Experimental, Departamento de Patología, Ciudad de México, Mexico.
Ricardo Márquez VelascoInstituto Nacional de Cardiología Ignacio Chávez, Departamento de Inmunología. Ciudad de México, Mexico.
Brenda Marquina-CastilloInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Sección de Patología Experimental, Departamento de Patología, Ciudad de México, Mexico.
Denise Anabella GiannoneCONICET - Universidad de Buenos Aires. Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS). Buenos Aires, Argentina.
Milagros Victoria AcevedoCONICET - Universidad de Buenos Aires. Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS). Buenos Aires, Argentina.
Maria Florencia QuirogaCONICET - Universidad de Buenos Aires. Instituto de Investigaciones Biomédicas en Retrovirus y SIDA (INBIRS). Buenos Aires, Argentina.
Rogelio Hernández-PandoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Sección de Patología Experimental, Departamento de Patología, Ciudad de México, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although anti-tuberculous therapy effectively eradicates

Indexed as

7-oxo-DHEAHost-directed therapyImmunotherapyPreclinical studyTuberculosis

Identifiers

PMID41245813
PMCPMC12612999

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.